An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to learn if initiating treatment with
BMS-51248 (Dapagliflozin) in combination with metformin XR can improve diabetes control in
patients with Type 2 Diabetes who do not receive any pharmacological treatment for diabetes,
when compared to initial treatment with monotherapy dapagliflozin or metformin XR. The safety
of this treatment will also be studied